Aiosyn Newsletter - August / September 2024
Automating quality control: saving time and money
Manual review of slides can be time-consuming, especially for high-volume laboratories, which often require more than 40 hours per week for these quality checks. However, with automated solutions like AiosynQC, we can drastically reduce this time. Our algorithm can scan 50 slides in just 1 to 1.5 minutes, flagging the affected slides and reducing the time spent on QC. Automation in quality control is transforming modern pathology labs, driving more efficient and seamless workflows.?Download Product Brief
The AI Act: Implications for AI-powered Medical Devices and Aiosyn
The Artificial Intelligence (AI) Act, the first major legislation to regulate Artificial Intelligence, came into force on August 1st. This legislation aims to ensure the responsible and ethical development and deployment of AI technologies. It emphasizes fundamental rights, safety, transparency, and ethical principles. For Aiosyn, this regulation aligns with our mission to revolutionize healthcare through innovative AI solutions. We actively implement relevant standards to ensure market access for reliable AI-based products, maintaining the highest safety and ethical standards. Check out the infographic - what do you need to know
?? 7th - 11th September
??Florence, Italy
?We will be at booth 89, ready for discussions and demonstrations of our automated QC and precision pathology software for breast cancer and kidney disease.
?
领英推荐
?? 16th - 20th September
??Paris, France
We look forward to discussing how our kidney image analyses can transform drug development studies with precise quantification and ultimately improve kidney transplant diagnostics.?
?
?? 9 - 10th October
??York, UK
Visit us at stand number 1 to discover how our AI-powered solutions, available through Sectra, can enhance your pathology assessments.
To schedule a meeting, feel free to reach us at [email protected] or reply to this email!